Back to today’s briefing

Story perspectives

FDA Releases 200+ Drug Approval Letters, Critics Skeptical

7/13/2025

50 7

Summary

Story summary

The FDA has unveiled over 200 complete response letters (CRLs) to boost transparency in its drug approval process, offering valuable insights into its decision-making. However, critics raise concerns about the thoroughness of this disclosure, pointing out that some letters fall outside the specified timeframe. More CRLs are anticipated in the future.

1 of 1

Story summary

The FDA has unveiled over 200 complete response letters (CRLs) to boost transparency in its drug approval process, offering valuable insights into its decision-making. However, critics raise concerns about the thoroughness of this disclosure, pointing out that some letters fall outside the specified timeframe. More CRLs are anticipated in the future.